RIPK2 and colorectal carcinoma: Interestingly, direct inhibition of these miR-146a targets were also effective in ameliorating enhanced CRC severity in miR-146a−/− mice (Fig. 6r, s), mice which we have shown express higher levels of RIPK2 and TRAF6 compared to WT.